Who Qualifies for a Gabapentin Dementia Lawsuit Claim?
The gabapentin dementia claims hinge on prescription counts and diagnosis age, not a lawsuit database or settlement fund to search.
Read more →Pharmaceutical
Gabapentin Dementia Lawsuit Eligibility Criteria
The six-prescription, pre-65-diagnosis screening rule for gabapentin dementia claims comes straight from a 2025 cohort study, not a court.
Read more →
Depo-Provera Lawsuit Payouts for Brain Tumor Claims
Why Depo-Provera brain tumor payouts remain unofficial, who qualifies under the 2026 settlement, and the deadline claimants face.
Read more →
Purdue Pharma Remains a Case Study in Mass Tort Bankruptcy Strategy
Purdue's bankruptcy consolidated opioid litigation into a single settlement process, creating a template for mass tort resolution that other defendants have since studied and...
Read more →
Purdue Pharma Faces Dissolution Following Five Billion Dollar Opioid Settlement Judgment
The company that manufactured OxyContin, the prescription opioid that fueled decades of addiction and overdose deaths, dissolved following a $7.4 billion...
Read more →
Pharmaceutical Kickback Lawsuit
Pharmaceutical kickback lawsuits are civil and criminal cases alleging that drug manufacturers illegally paid healthcare providers—doctors, hospitals, and...
Read more →
Pharmaceutical Manufacturing Defect Lawsuit
A pharmaceutical manufacturing defect lawsuit is a legal claim alleging that a prescription drug or medical device was manufactured improperly, resulting...
Read more →
Instagram Self Harm Lawsuit
The Instagram self-harm lawsuit represents the first major jury trial testing whether social media platforms bear legal responsibility for mental health...
Read more →
Social Media Harm Lawsuit
Social media harm lawsuits are a growing category of mass tort litigation alleging that Meta (Facebook and Instagram), Google (YouTube), ByteDance...
Read more →
Purdue Pharma Opioid Lawsuit Settlement
The Purdue Pharma opioid lawsuit settlement totals $7.4 billion, with U.S. Bankruptcy Judge Sean Lane formally approving the agreement in November 2025.
Read more →